These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 3022508)

  • 21. ACE inhibitors.
    Aust Nurses J; 1988 Aug; 18(2):27-8. PubMed ID: 2848480
    [No Abstract]   [Full Text] [Related]  

  • 22. Lisinopril--another ACE inhibitor.
    Drug Ther Bull; 1989 Apr; 27(8):31-2. PubMed ID: 2562398
    [No Abstract]   [Full Text] [Related]  

  • 23. Angiotensin-converting-enzyme inhibitors in treatment of heart failure.
    Lancet; 1985 Oct; 2(8459):811-2. PubMed ID: 2864536
    [No Abstract]   [Full Text] [Related]  

  • 24. [The use of lisinopril for congestive heart failure].
    Amodeo C
    Arq Bras Cardiol; 1990 Aug; 55 Suppl A():A14-7. PubMed ID: 1965521
    [No Abstract]   [Full Text] [Related]  

  • 25. Evaluation of angiotensin-converting enzyme inhibitor in congestive heart failure.
    Matsuo H
    Intern Med; 1996 Jan; 35(1):65-7. PubMed ID: 8652943
    [No Abstract]   [Full Text] [Related]  

  • 26. Optimizing the use of ACE inhibitors in patients with congestive heart failure.
    Tsikouris JP
    Conn Med; 1999 Feb; 63(2):91-3. PubMed ID: 10188339
    [No Abstract]   [Full Text] [Related]  

  • 27. Are ACE inhibitors equal in congestive heart failure?
    Reid J
    S Afr Med J; 1993 Oct; Suppl():1-3. PubMed ID: 8191309
    [No Abstract]   [Full Text] [Related]  

  • 28. Overview: the role of angiotensin-converting enzyme inhibitors in cardiovascular therapy.
    Abrams WB; Davies RO; Ferguson RK
    Fed Proc; 1984 Apr; 43(5):1314-21. PubMed ID: 6323221
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Ednit in the treatment of congestive heart failure in chronic obstructive bronchitis].
    Shkol'nik MA; Sheĭkh AT; Butorov IV; Duduleĭ RF
    Klin Med (Mosk); 2000; 78(7):56-8. PubMed ID: 10979645
    [No Abstract]   [Full Text] [Related]  

  • 30. [What have we learned about inhibitors of the renin-angiotensin system?].
    Waeber B; Nussberger J; Brunner HR
    Ann Endocrinol (Paris); 1986; 47(3):167-77. PubMed ID: 3022638
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Perspectives for enalapril in the therapy of coronary heart disease. European Cardiology Symposium, Montreux, February 1997].
    Dtsch Med Wochenschr; 1997; 122(21 Suppl Perspektiv):1-8. PubMed ID: 9439478
    [No Abstract]   [Full Text] [Related]  

  • 32. [Drug therapy of congestive heart failure].
    Liu P; Zhang X
    Zhonghua Nei Ke Za Zhi; 1997 Sep; 36(9):634-7. PubMed ID: 10436974
    [No Abstract]   [Full Text] [Related]  

  • 33. [Comparison of candesartan, enalapril and their combination in congestive heart failure].
    Rapezzi C
    Ital Heart J Suppl; 2000 Mar; 1(3):429-30. PubMed ID: 10815278
    [No Abstract]   [Full Text] [Related]  

  • 34. Effects of subchronic treatment with trandolapril and enalapril on cardiovascular morphologic alterations in the aged spontaneously hypertensive rat with heart failure.
    Secchi J; Lecaque D; Dunn FW; Jouquey S; Auberval UD; Benzoni F; Sirugue O; Hamon G
    J Cardiovasc Pharmacol; 1994; 23 Suppl 4():S30-7. PubMed ID: 7527099
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Converting enzyme inhibition in hypertension and congestive heart failure. Rotterdam, The Netherlands, March 16, 1985.
    J Cardiovasc Pharmacol; 1986; 8 Suppl 1():S1-70. PubMed ID: 2422486
    [No Abstract]   [Full Text] [Related]  

  • 36. Angiotensin-converting enzyme inhibitors in hypertension and congestive heart failure.
    Gavras I; Gavras H
    Adv Intern Med; 1990; 35():249-67. PubMed ID: 2405595
    [No Abstract]   [Full Text] [Related]  

  • 37. [The value of lysinopril in cardiac insufficiency].
    Lambert M; Luccioni R
    Rev Prat; 1990 Oct; 40(23 Suppl):53-8. PubMed ID: 2176346
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Recent Advances in Angiotensin-Converting Enzyme Inhibition in the Treatment of Hypertension and Heart Failure. Symposium proceedings. Barcelona, Spain, August 30, 1992.
    Am J Cardiol; 1993 Jun; 71(17):1E-68E. PubMed ID: 8101035
    [No Abstract]   [Full Text] [Related]  

  • 39. Does the duration of action of angiotensin converting enzyme inhibitors affect their safety and adverse effects?
    Frank GJ
    J Hypertens Suppl; 1989 Sep; 7(5):S17-22. PubMed ID: 2553900
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Enalapril, a nonsulfhydryl angiotensin-converting enzyme inhibitor.
    Vlasses PH; Larijani GE; Conner DP; Ferguson RK
    Clin Pharm; 1985; 4(1):27-40. PubMed ID: 2982541
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.